Something Powerful

Tell The Reader More

The headline and subheader tells us what you're offering, and the form header closes the deal. Over here you can explain why your offer is so great it's worth filling out a form for.

Remember:

  • Bullets are great
  • For spelling out benefits and
  • Turning visitors into leads.

Medius Deal Watch January 2018

One key question for 2018 is whether the recent US tax changes will have an...

Read More

STORM Therapeutics leads the way in RNA epigenetic...

Key learnings: STORM Therapeutics is developing small molecule inhibitors o...

Read More

Interview with Inmedix’s Andrew J. Holman

Andrew J. Holman, Co-Founder and Chief Executive Officer at Inmedix, talks ...

Read More

Interview with Repositive’s Fiona Nielsen

Fiona Nielsen, Founder and Chief Executive Officer at Repositive, explains ...

Read More

Interview with TxCell’s Stéphane Boissel

Stéphane Boissel, Chief Executive Officer at TxCell, talks to PharmaVenture...

Read More

Interview with Priavoid’s Dieter Willbold

Dieter Willbold, Founder and Chairman of the Supervisory Board at Priavoid,...

Read More

Interview with QuantuMDx’s Elaine Warburton

Elaine Warburton OBE, Chief Executive Officer at QuantuMDx, discusses the c...

Read More

Biotech vs medtech: divergence in intellectual pro...

The landscape of innovation and investment in the healthcare sector has cha...

Read More

Biotech vs medtech: differences in mapping an IP p...

IP portfolio management is often overlooked, but is extremely important if ...

Read More

The New Cambrian Era for Biotech Start-ups

Healthcare is the hottest new sector for start-ups when it comes to new tec...

Read More

Anatomy of a…biotech IPO: Q&A with Neil Clark

On Tuesday 6 February 2018, leading life sciences companies will share thei...

Read More

Anatomy of a…private finance raise: Q&A with Marti...

On Tuesday 6 February 2018, leading life sciences companies will share thei...

Read More

Add Your Response